Hayden Royal LLC Has $379,000 Position in UnitedHealth Group Inc (NYSE:UNH)

Share on StockTwits

Hayden Royal LLC boosted its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 34.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,461 shares of the healthcare conglomerate’s stock after buying an additional 371 shares during the period. Hayden Royal LLC’s holdings in UnitedHealth Group were worth $379,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of UNH. Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter worth $2,343,175,000. Thoroughbred Financial Services LLC boosted its stake in UnitedHealth Group by 25,321.4% during the second quarter. Thoroughbred Financial Services LLC now owns 1,922,872 shares of the healthcare conglomerate’s stock worth $192,287,000 after buying an additional 1,915,308 shares in the last quarter. Sanders Capital LLC boosted its stake in UnitedHealth Group by 50.2% during the second quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock worth $1,255,689,000 after buying an additional 1,546,140 shares in the last quarter. FMR LLC boosted its stake in UnitedHealth Group by 1.9% during the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock worth $16,063,258,000 after buying an additional 1,232,189 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 9.1% during the fourth quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after acquiring an additional 965,763 shares during the period. Hedge funds and other institutional investors own 85.65% of the company’s stock.

A number of brokerages have issued reports on UNH. SunTrust Banks cut their price objective on UnitedHealth Group to $300.00 and set a “buy” rating for the company in a report on Wednesday, April 17th. They noted that the move was a valuation call. Barclays cut their price objective on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a report on Wednesday, April 17th. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 15th. Cantor Fitzgerald set a $310.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Finally, Citigroup raised UnitedHealth Group from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $247.00 to $280.00 in a report on Friday, May 10th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $295.06.

In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total transaction of $2,480,000.00. Following the completion of the sale, the director now directly owns 187,663 shares of the company’s stock, valued at approximately $46,540,424. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $246.40, for a total value of $1,232,000.00. Following the sale, the director now directly owns 187,979 shares of the company’s stock, valued at $46,318,025.60. The disclosure for this sale can be found here. Insiders have sold a total of 37,000 shares of company stock valued at $9,195,620 over the last three months. Company insiders own 0.82% of the company’s stock.

UnitedHealth Group stock opened at $249.22 on Wednesday. The firm has a 50-day simple moving average of $251.38. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94. The company has a market capitalization of $235.62 billion, a PE ratio of 19.35, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.46 by $0.14. The business had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the previous year, the business posted $3.14 earnings per share. Equities analysts predict that UnitedHealth Group Inc will post 14.82 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What is the NASDAQ Stock Market?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Northland Securities Reiterates Hold Rating for Green Dot
Northland Securities Reiterates Hold Rating for Green Dot
Mastercard  Earns “Outperform” Rating from William Blair
Mastercard Earns “Outperform” Rating from William Blair
Huntington Bancshares  Rating Lowered to Neutral at DA Davidson
Huntington Bancshares Rating Lowered to Neutral at DA Davidson
Raymond James Upgrades M.D.C.  to “Strong-Buy”
Raymond James Upgrades M.D.C. to “Strong-Buy”
Federal Realty Investment Trust  Raised to Buy at Mizuho
Federal Realty Investment Trust Raised to Buy at Mizuho
Shiloh Industries  Lifted to “Neutral” at Bank of America
Shiloh Industries Lifted to “Neutral” at Bank of America


© 2006-2019 Ticker Report